{"id":163585,"date":"2022-10-03T01:51:05","date_gmt":"2022-10-03T05:51:05","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/belite-bio-presented-12-month-interim-results-of-lbs-008-phase-1b-2-study-in-adolescent-stargardt-disease-at-aao-annual-meeting-2022\/"},"modified":"2024-08-18T11:45:22","modified_gmt":"2024-08-18T15:45:22","slug":"belite-bio-presented-12-month-interim-results-of-lbs-008-phase-1b-2-study-in-adolescent-stargardt-disease-at-aao-annual-meeting-2022","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/belite-bio-presented-12-month-interim-results-of-lbs-008-phase-1b-2-study-in-adolescent-stargardt-disease-at-aao-annual-meeting-2022.php","title":{"rendered":"Belite Bio Presented 12-Month Interim Results of LBS-008 Phase 1b\/2 Study in Adolescent Stargardt Disease at AAO Annual Meeting 2022"},"content":{"rendered":"<p><![CDATA[SAN DIEGO, Oct.  01, 2022  (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE), a San Diego based clinical stage biopharmaceutical drug development company targeting currently untreatable eye diseases, today presented one-year data from their ongoing two-year Phase 2 clinical study of Tinlarebant in STGD1 as part of the oral presentation series at the Annual Meeting of the American Academy of Ophthalmology (AAO) held during September 30 - October 3, 2022 at McCormick Place, Chicago.]]><\/p>\n<p>Read more here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/10\/01\/2526407\/0\/en\/Belite-Bio-Presented-12-Month-Interim-Results-of-LBS-008-Phase-1b-2-Study-in-Adolescent-Stargardt-Disease-at-AAO-Annual-Meeting-2022.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Belite Bio Presented 12-Month Interim Results of LBS-008 Phase 1b\/2 Study in Adolescent Stargardt Disease at AAO Annual Meeting 2022\">Belite Bio Presented 12-Month Interim Results of LBS-008 Phase 1b\/2 Study in Adolescent Stargardt Disease at AAO Annual Meeting 2022<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read more here: Belite Bio Presented 12-Month Interim Results of LBS-008 Phase 1b\/2 Study in Adolescent Stargardt Disease at AAO Annual Meeting 2022 <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/belite-bio-presented-12-month-interim-results-of-lbs-008-phase-1b-2-study-in-adolescent-stargardt-disease-at-aao-annual-meeting-2022.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-163585","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/163585"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=163585"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/163585\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=163585"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=163585"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=163585"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}